This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
Prostheses do not go to the Far East
The localization of medical production even in the TOP for investors is not profitable yet
The Government of the Russian Federation has taken a course to strengthen cooperation in the medical sphere with China and other countries of the Asia-Pacific region. In this sense, the Russian Far East has good chances to become an excellent platform for the placement of modern and high-tech production of medical products. But while the preference is given to the regions located closer to Moscow.
Orthopedists and traumatologists of all countries united in Moscow at the first professional Eurasian Forum in late June. As part of this event, a joint operation of Russian orthopedic surgeons with a colleague from the PRC took place: the patient had an endoprosthesis (a part designed to replace any internal damaged organ) of a hip joint made in China. From August 2017, these high-quality and much-needed products will start to be produced in Russia.
Instead of the planned one and a half hours, the operation lasted about three and a half. As the surgeons who left the operating room, the head of the clinic for arthroplasty of the joints of the Central Institute of Traumatology and Orthopedics named after V.I. N.N. Priorova (CITO) Nikolay Zagorodny and Deputy Director of the Department of Arthroplasty of the Main Military Hospital of the People's Liberation Army of China Dr. Zhang Guoqiang from Beijing - an unexpected happened: a 65-year-old patient suffering from osteoarthritis deformans turned out to be too small for her size pelvic bone with superdense fat cover, and the anterior wall of the acetabulum, to which the hip joint is usually attached, was practically absent.
“But after sweating badly, we found a way to combine the details of the endoprosthesis with each other in such a way that in the end he stood up perfectly. We are satisfied. One day after the operation, the patient will be able to walk. So far, however, on crutches, ”said Nikolai Zagorodni.
For his Chinese colleague, this is the first operation and the first patient in Russia. “Since childhood, I wanted to visit your country and now, thanks to the Eurasian Orthopedic Forum, I ended up here. I am very proud that I managed to work with Russian professionals of the highest class and I hope that our Chinese endoprostheses, recognized all over the world, will now also serve well for patients from Russia, "Zhang Guoqiang modestly noted, who has more than twenty years of experience behind him. surgical practice and hundreds of people saved from wheelchairs.
As for the articular endoprosthesis itself, or implant, it is developed and manufactured in China on the basis of the enterprises of the Neuton concern (one of the manufacturers of medical equipment and medical devices on a global scale). Since August this year, Neuton has been opening a localized production of endoprostheses in Russia, at the Rameev Technopark in the Penza Region. In other words, the badly needed medical products will be mass-produced on Russian machines, but using Chinese technologies. “This is a very important acquisition for Russian traumatology and orthopedics, considering that in all of Russia so far only two companies are engaged in the manufacture of such products,” emphasizes Nikolay Zagorodny.
EastRussia help. The First Eurasian Orthopedic Forum (EOF) in Moscow, along with the main topic (traumatology and orthopedics), included dozens of other medical areas. Within its framework, more than 200 events were held for medical specialists, government agencies and business representatives in twenty scientific and practical disciplines - from anesthesiology and resuscitation, radiation diagnostics, pharmacology, oncology to disaster medicine, military field surgery and complex rehabilitation. There was an exhibition of Russian and foreign medical products and equipment. Particular attention was paid to the experience of China, whose delegation headed by Zhang Yingze, President of the PRC Orthopedic Association, became one of the largest at the EOF. Also, the event was attended by communities of traumatologists and orthopedists from Austria, Azerbaijan, Armenia, Bangladesh, Belarus, Greece, India, Kazakhstan, Kyrgyzstan, China, Malaysia, Saudi Arabia, Serbia, Singapore, Uzbekistan and other countries.
QUESTION OF NATIONAL SECURITY
Actually, the localization of the production of medical equipment and products on Russian territory, the attraction of foreign investments here for this purpose became one of the main topics of the First Eurasian Orthopedic Forum, which brought together in Moscow on June 29-30 more than three thousand medical orthopedic specialists and traumatologists from 72 countries of all major regions of the world. The initiators and organizers of the forum were Russian and civilian doctors - in particular, the FSBI CITO named after N.N. Priorov and FGKU GVKG them. Burdenko - with the support of the Ministry of Health and the Ministry of Industry and Trade of the Russian Federation.
The fact is that orthopedics (diagnostics and treatment of deformities and dysfunctions of the musculoskeletal system) and traumatology (diagnostics and treatment of mechanical injuries of the human musculoskeletal system) are developing quite rapidly in Russia today. As Deputy Minister of Industry and Trade Sergei Tsyb noted in his report at the forum, the production of medical devices in this area in Russia in 2016 increased by 16% compared to 2015, while in the world - by only 7-8%.
However, with regard to the Russian market of medical products for these areas - and this is mainly the above-mentioned implants made of titanium alloys - that is only 0,7-0,8% of the world, and the share of domestic products for orthopedics and traumatology in the country accounts for no more than 12%. The rest of the products have to be imported from abroad. And the preservation of this trend is dangerous: if the West, in its sanctions policy against Russia, places obstacles for imports in this area, then the country risks finding itself in a situation close to a national catastrophe. Already today, according to one of the main organizers and participants of the forum, the President of the Association of Traumatology-Orthopedists, Director of the Center for Information Technologies, Academician of the Russian Academy of Sciences Sergey Mironov, the rates of growth of the musculoskeletal system morbidity exceed the growth of the general morbidity in the country. In Russia, about 20 million people suffer from these diseases. Given the trend of population aging by 2025, this number may increase by several times. Therefore, the problem of import substitution and localization of the production of endoprostheses and related products is more acute than ever.
FAR EAST NOT ANY PRIORITY
One of the options for the localization of such production could be the advanced development territories (TOR) in the Far East, which have a number of preferential tax and customs benefits. But, as the speeches of the forum participants have shown, so far foreigners prefer the regions located closer to Moscow as sites for placing the production of implants.
"Of course, we are very interested in the TOR and Vladivostok free port regimes and we, in principle, are considering the possibility of localizing here the production of medical products under the Russian brand, but developed in China. But for now we prefer Tomsk, that is Siberia, as the location. This city is approximately equidistant from China and Central Russia. Therefore, in terms of logistics so far more convenient for our Chinese partner than Vladivostok or Khabarovsk. Taking into account, of course, the target audience - citizens of the Russian Federation and other states of the Eurasian Economic Union, who need endoprosthetics, "the representative of the Chinese company Double Medical, Darya Lenina, told EastRussia.
Similar opinions were expressed by other participants of the Eurasian Orthopedic Forum, focused on joint production with colleagues from Russia’s neighboring countries in the Far East: China, Korea and Japan.
Recall about the plans to create an international medical cluster in the free port of Vladivostok, the Ministry for the Development of the Far East (Ministry of Eastern Development) announced at the end of 2015 year. It was about creating a network of medical institutions in most of Primorye with the participation of primarily Chinese, South Korean and Japanese investments (as part of changes to the federal law "On the International Medical Cluster ..." of June 29 2015). It was thought that the medical cluster will unite more than a hundred companies that produce medical equipment, products and provide health services. But so far the matter has not progressed further than these intentions.